Bayes BLUEPRINT
Asset Intelligence
Compress 6-8 Weeks of Research into 2 Hours
Transforms a sponsor's Target Product Profile (TPP) into an evidence-backed development blueprint
Automated TPP Intake & Parsing: Ingests indication, MoA, route, and label claims with immediate analyst verification.
Ranked Analogue Discovery: Identifies active analogues and cross-verifies approvals
Regulatory Summary Review Insights: Synthesizes FDA Review history with page-level citations for regulatory hurdles.
Market Outlook & eNPV Modeling: Generates addressable patient funnels, 10-year sales forecasts, and risk-adjusted valuation.Coming Q4
The Evidence Rule
“If a value has no verified public or benchmark source, it becomes an explicitly flagged gap — never a silent default.”
Analyst Sovereignty
Human clinical judgment is preserved. Any manual override survives automated platform re-runs.
Board-Ready Deliverables
Export comprehensive PDF/PPTX decks with full clinical Gantts and cost schedules in one click.
See Bayes BLUEPRINT on your own programme.
Already have an account? adv.bayespredictive.com